Cohance Lifesciences Stock Plummets to New 52-Week Low at Rs. 615.1

Cohance Lifesciences has reached a significant milestone by hitting a new 52-week low of Rs. 615.1 today, marking a notable decline in its stock performance. This drop comes as the company has faced a challenging period, with the stock underperforming its sector by 1.41%. Over the past 12 days, Cohance Lifesciences has seen a consecutive fall, resulting in a substantial 27.08% decrease in returns. The stock's performance has been consistently below key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a persistent downward trend. In the broader market context, the Sensex opened lower and is currently trading at 84,318.06, reflecting a slight decline of 0.19%. Cohance Lifesciences has experienced a challenging year, with a 51.31% decline in its stock value compared to the Sensex's positive performance of 8.66%. The company's financial metrics, including a low operating cash flow and declining profit before tax, further highlight the difficulties it faces in the current market environment.